Details for New Drug Application (NDA): 022369

✉ Email this page to a colleague

NDA 022369 describes LATISSE, which is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the LATISSE profile page.

The generic ingredient in LATISSE is bimatoprost. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the bimatoprost profile page.

Summary for 022369

Tradename:	LATISSE
Applicant:	Abbvie
Ingredient:	bimatoprost
Patents:	1

Pharmacology for NDA: 022369

Medical Subject Heading (MeSH) Categories for 022369

Antihypertensive Agents

Suppliers and Packaging for NDA: 022369

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
LATISSE	bimatoprost	SOLUTION/DROPS;TOPICAL	022369	NDA	Allergan, Inc.	0023-3616	0023-3616-05	1 BOTTLE, DROPPER in 1 CARTON (0023-3616-05) / 5 mL in 1 BOTTLE, DROPPER
LATISSE	bimatoprost	SOLUTION/DROPS;TOPICAL	022369	NDA	Allergan, Inc.	0023-3616	0023-3616-70	1 BOTTLE, DROPPER in 1 CARTON (0023-3616-70) / 3 mL in 1 BOTTLE, DROPPER

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION/DROPS;TOPICAL			Strength	0.03%
Approval Date:	Dec 24, 2008	TE:	AT	RLD:	Yes
Patent:	⤷ Subscribe	Patent Expiration:	May 25, 2024	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	METHOD OF INCREASING HAIR GROWTH
Patent:	⤷ Subscribe	Patent Expiration:	May 25, 2024	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	METHOD OF STIMULATING HAIR GROWTH

Expired US Patents for NDA 022369

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	LATISSE	bimatoprost	SOLUTION/DROPS;TOPICAL	022369-001	Dec 24, 2008	⤷ Subscribe	⤷ Subscribe
Abbvie	LATISSE	bimatoprost	SOLUTION/DROPS;TOPICAL	022369-001	Dec 24, 2008	⤷ Subscribe	⤷ Subscribe
Abbvie	LATISSE	bimatoprost	SOLUTION/DROPS;TOPICAL	022369-001	Dec 24, 2008	⤷ Subscribe	⤷ Subscribe
Abbvie	LATISSE	bimatoprost	SOLUTION/DROPS;TOPICAL	022369-001	Dec 24, 2008	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.